Toward Higher QA: From Parametric Release of Sterile Parenteral Products to PAT for Other Pharmaceutical Dosage Forms

References

1. 1.↵
   ICH. ICH Harmonised Tripartite Guideline: Pharmaceutical Development Q6A. 1999.
2. 2.↵
   ICH. ICH Harmonised Tripartite Guideline: Pharmaceutical Development Q6B. 1999.
3. 3.↵
   1. Yu L.

   Pharmaceutical quality by design: product and process development, understanding, and control. Pharm. Res. 2008, 25 (4), 781– 791.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Yihong Q.,
   2. Yisheng C.,
   3. Geoff G. Z. Z.,
   4. Lirong L.,
   5. William R. P.

   1. Jiang W.,
   2. Yu L. X.

   Modern Pharmaceutical Quality Regulations: Question-based Review. In Developing Solid Oral Dosage Forms; Yihong Q., Yisheng C., Geoff G. Z. Z., Lirong L., William R. P. Eds.; Academic Press: San Diego, CA, 2009; pp 885– 901.
5. 5.↵
   1. Lionberger R.,
   2. Lee S.,
   3. Lee L.,
   4. Raw A.,
   5. Yu L.

   Quality by design: concepts for ANDAs. AAPS Journal 2008, 10 (2), 268– 276.

   OpenUrlPubMed
6. 6.↵
   1. Agalloco J. P.,
   2. Carleton F. J.

   1. Scott B. S.,
   2. Wilcock A

   Process Analytical Technology and Validation. In Validation of Pharmaceutical Processes; 3rd ed.; Agalloco J. P., Carleton F. J. Eds.; Informa Healthcare, Inc.: New York, 2008; pp 583– 605.
7. 7.↵
   FDA. 2004 12 August 2010. Guidance for Industry PAT: A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070305.pdf.
8. 8.↵
   1. Hinz D. C.

   Process analytical technologies in the pharmaceutical industry: the FDA's PAT initiative. Anal. Bioanal. Chem. 2005, 384 (5), 1036– 1042.

   OpenUrl
9. 9.↵
   1. Maes I.,
   2. Liedekerke B. V.

   The need for a broader perspective if process analytical technology implementation is to be successful in the pharmaceutical sector. Journal of Pharmaceutical Innovation 2006, 1 (1), 19– 21.

   OpenUrl
10. 10.↵
    ICH. 2009 04 October 2010. ICH Harmonised Tripartite Guideline: Pharmaceutical Development Q8R (2). http://www.ich.org/LOB/media/MEDIA4986.pdf.
11. 11.↵
    1. Drennen J. K.

    Quality by design: what does it really mean? Journal of Pharmaceutical Innovation 2007, 2 (3–4), 65– 66.

    OpenUrl
12. 12.↵
    1. Staples M. A.

    The Concept of Quality-by-Design. Pharmaceutical Stability Testing to Support Global Markets; New York: Springer, 2010; Vol. XII, pp 101– 106.

    OpenUrl
13. 13.↵
    1. Ganzer W. P.,
    2. Materna J. A.,
    3. Mitchell M. B.,
    4. Wall L. K.

    Current thoughts on critical process parameters and API synthesis. Pharm. Technol. 2005, 29 (7), 46– 66.

    OpenUrl
14. 14.↵
    1. Woedtke T. V.,
    2. Kramer A.

    The limits of sterility assurance. GMS Krankenhaushygiene Interdisziplinär 2008, 3 (3).
15. 15.↵
    EMEA. 2010 01 September 2010. Guideline on Real Time Release Testing (formerly Guideline on Parametric Release). (http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/03/WC500075028.pdf.
16. 16.↵
    1. Williams K. L.

    1. Haberer K.

    Terminal Sterilization and Parametric Release. In Microbial Contamination Control in Parenteral Manufacturing, Drugs and the Pharmmaceutical Sciences; Williams K. L. Ed.; Marcel Dekker, Inc.: New York, 2004; pp 419– 447.
17. 17.↵
    PIC/S. 2007 Guidance on Parametric Release. http://www.picscheme.org//publication.php?download&file=cGktMDA1LTMtcGFyYW1ldHJpYy1yZWxlYXNlLnBkZg__. Accessed 04 October 2010.
18. 18.↵
    1. Chirkot T. S.

    The relevance of continuous solid oral dosage processing and NIR spectroscopy in meeting the needs of QbD and PAT. Pharm. Technol. 2009, 33 (10), 112– 120.

    OpenUrl
19. 19.↵
    1. Shrestha B.,
    2. Basnett H.,
    3. Raj P. M.,
    4. Patel S. S.,
    5. Das M.,
    6. Verma N. K.

    Process analytical technology: a quality assurance tool. Research Journal of Pharmacy and Technology 2009, 2 (2), 225– 227.

    OpenUrl
20. 20.↵
    USP 〈1222〉 Terminally Sterilized Pharmaceutical Products: Parametric Release. In USP, United States Pharmacopeial Convention. Volume 29. US NF: Rockville, MD, 2002.
21. 21.↵
    1. Aulton M. E.

    1. Walsh S. E.,
    2. Maillard J.-Y.

    Principles of Sterilisation. In Aulton's Pharmaceutics: The Design and Manufacture of Medicines, 3rd ed.; Aulton M. E. Ed.; Elsevier Limited: Philadelphia, PA, 2007; pp 242– 250.
22. 22.↵
    1. Aulton M. E.

    1. Maillard J.-Y.,
    2. Walsh S. E.

    Sterilisation in Practice. In Aulton's Pharmaceutics: The Design and Manufacture of Medicines, 3rd ed.; Aulton M. E. Ed.; Elsevier Limited: Philadelphia, PA, 2007; pp 251– 265.
23. 23.↵
    1. Williams K. L.

    1. Gonzales L.

    Raw Material Contamination Control. In Microbial Contamination and Control In Parenteral Manufacturing, Drugs and the Pharmaceutical Sciences; Williams K. L. Ed.; Marcel Dekker Inc.: New York, 2004; pp 449– 160.
24. 24.↵
    1. Williams K. L.

    1. Gail L.,
    2. Stanischewski D.

    Airborne Contamination Control. In Microbial Contamination Control in Parenteral Manufacturing, Drugs and the Pharmaceutical Sciences; Williams K. L. Ed.; Marcel Dekker Inc.: New York, 2004; pp 215– 232.
25. 25.↵
    1. Williams K. L.

    1. Emerson J.,
    2. Esswein P.,
    3. Gail L.,
    4. Pflugmacher U.

    Environmental Monitoring. In Microbial Contamination Control in Parenteral Manufacturing, Drugs and the Pharmaceutical Sciences; Williams K. L. Ed.; Marcel Dekker Inc.: New York, 2004; pp 609– 624.
26. 26.↵
    1. Agalloco J. P.,
    2. Carleton F. J.

    1. Hallworth M.

    Monitoring of Viable Particles. In Validation of Pharmaceutical Processes, 3rd ed.; Agalloco J. P., Carleton F. J. Eds.; Informa Healthcare: New York, 2008; pp 339– 355.
27. 27.↵
    1. Agalloco J. P.,
    2. Carleton F. J.

    1. Deschenes P. D.

    Viable Environmental Microbiological Monitoring. In Validation of Pharmaceutical Processes, 3rd ed.; Agalloco J. P., Carleton F. J. Eds.; Informa Healthcare: New York, 2008; pp 357– 369.
28. 28.↵
    1. Agalloco J. P.,
    2. Carleton F. J.

    1. Berger T. J.,
    2. Trupp K. D.

    Validation of Terminal Sterilisation. In Validation of Pharmaceutical Processes, 3rd ed.; Agalloco J. P., Carleton F. J. Eds.; Informa Healthcare: New York, 2008; pp 187– 199.
29. 29.↵
    1. Agalloco J. P.,
    2. Carleton F. J.

    1. Case L. B.,
    2. Heffernan G. D.

    Dry Heat Sterilisation and Depyrogenation Validation and Monitoring. In Validation of Pharmaceutical Processes, 3rd ed.; Agalloco J. P., Carleton F. J. Eds.; Informa Healthcare: New York, 2008; pp 223– 240.
30. 30.↵
    1. Agalloco J. P.,
    2. Carleton F. J.

    1. Gillis J. R.,
    2. Mosley G.

    Validation of Ethylene Oxide Sterilization Processes. In Validation of Pharmaceutical Processes, 3rd ed.; Agalloco J. P., Carleton F. J. Eds.; Informa Healthcare: New York, 2008; pp 241– 262.
31. 31.↵
    1. Agalloco J. P.,
    2. Carleton F. J.

    1. Jacobs G. P.

    Validation of the Radiation Sterilisation of Pharmaceuticals. In Validation of Pharmaceutical Processes, 3rd ed.; Agalloco J. P., Carleton F. J. Eds.; Informa Healthcare: New York, 2008; pp 269– 275.
32. 32.↵
    1. Agalloco J. P.,
    2. Carleton F. J.

    1. William G.,
    2. Lindboe J.

    Validation of Container Preparation Processes. In Validation of Pharmaceutical Processes, 3rd ed.; Agalloco J. P., Carleton F. J. Eds.; Informa Healthcare: New York, 2008; pp 371– 379.
33. 33.↵
    1. Agalloco J. P.,
    2. Carleton F. J.

    1. DeSantis P.

    Steam Sterilization in Autoclaves. In Validation of Pharmaceutical Processes, 3rd ed.; Agalloco J. P., Carleton F. J. Eds.; Informa Healthcare: New York, 2008; pp 175– 186.
34. 34.↵
    1. Agalloco J. P.,
    2. Carleton F. J.

    1. Munson T. E.

    Regulatory Aspects of Validation. In Validation of Pharmaceutical Processes, 3rd ed.; Agalloco J. P., Carleton F. J. Eds.; Informa Healthcare: New York, 2008; pp 709– 714.
35. 35.↵
    FDA. 2004. Pharmaceutical cGMPs for the 21st century: A risk based approach. http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/Manufacturing/QuestionsandAnswersonCurrentGoodManufacturingPracticescGMPforDrugs/UCM176374.pdf. 12 August 2010.
36. 36.↵
    1. Weinberg S.

    Cost-contained Regulatory Compliance: For the Pharmaceutical, Biologics and Medical Device Industries, 1st ed.; Weinberg S. Ed.; John Wiley & Sons, Inc.: Hoboken, NJ, 2011; pp 44.
37. 37.↵
    1. John L.

    1. Skibsted E.,
    2. Engelsen S. B.

    Spectroscopy for Process Analytical Technology (PAT). In Encyclopedia of Spectroscopy and Spectrometry; John L. Ed.; Academic Press: Oxford, 2010; pp 2651– 2661.
38. 38.↵
    1. Rios M.

    Continuous processing—finally. Pharm. Technol. 2007, 31 (4), 64– 67.

    OpenUrl
39. 39.↵
    1. Pellek A.,
    2. van Arnuma P.

    Continuous processing: moving with or against the manufacturing flow? Pharm. Technol. 2008, 32 (9), 52– 58.

    OpenUrl
40. 40.↵
    1. Bakeev K. A.

    1. Simpson M. B.

    Near-Infrared Spectroscopy for Process Analytical Chemistry: Theory, Technology and Implementation. In Process Analytical Technology: Spectroscopic Tools and Implementation Strategies for the Chemical and Pharmaceutical Industries; Bakeev K. A. Ed.; Blackwell Publishing Ltd.: Oxford, 2005; pp 39– 90.
41. 41.↵
    1. Yihong Q.,
    2. Yisheng C.,
    3. Geoff G. Z. Z.,
    4. Lirong L.,
    5. William R. P.

    1. Sever N. E.,
    2. Warman M.,
    3. Mackey S.,
    4. Dziki W.,
    5. Jiang M.

    Process Analytical Technology in Solid Dosage Development and Manufacturing. In Developing Solid Oral Dosage Forms; Yihong Q., Yisheng C., Geoff G. Z. Z., Lirong L., William R. P. Eds.; Academic Press: San Diego, 2009; pp 827– 841.
42. 42.↵
    1. Higgins J. P.,
    2. Arrivo S. M.,
    3. Thurau G.,
    4. Green R. L.,
    5. Bowen W.,
    6. Lange A.,
    7. Templeton A. C.,
    8. Thomas D. L.,
    9. Reed R. A.

    Spectroscopic approach for on-line monitoring of particle size during the processing of pharmaceutical nanoparticles. Anal Chem. 2003, 75 (8), 1777– 85.

    OpenUrlPubMed
43. 43.↵
    1. Sekulic S. S.,
    2. Ward H. W.,
    3. Brannegan D. R.,
    4. Stanley E. D.,
    5. Evans C. L.,
    6. Sciavolino S. T.,
    7. Hailey P. A.,
    8. Aldridge P. K.

    On-line monitoring of powder blend homogeneity by near-infrared spectroscopy. Anal. Chem. 1996, 68 (3), 509– 513.

    OpenUrlPubMed
44. 44.↵
    1. El-Hagrasy A. S.,
    2. Morris H. R.,
    3. D'Amico F.,
    4. Lodder R. A.,
    5. Drennen J. K 3rd..

    Near-infrared spectroscopy and imaging for the monitoring of powder blend homogeneity. J. Pharm Sci. 2001, 90 (9), 1298– 1307.

    OpenUrlPubMed
45. 45.↵
    1. Blanco M.,
    2. Gozález Bañó R.,
    3. Bertran E.

    Monitoring powder blending in pharmaceutical processes by use of near infrared spectroscopy. Talanta 2002, 56 (1), 203– 212.

    OpenUrlPubMed
46. 46.↵
    1. Berntsson O.,
    2. Danielsson L. G.,
    3. Lagerholm B.,
    4. Folestad S.

    Quantitative in-line monitoring of powder blending by near infrared reflection spectroscopy. Powder Technol. 2002, 123 (2–3), 185– 193.

    OpenUrl
47. 47.↵
    1. El-Hagrasy A. S.,
    2. D'Amico F.,
    3. Drennen J. K 3rd..

    A process analytical technology approach to near-infrared process control of pharmaceutical powder blending. Part I: D-optimal design for characterization of powder mixing and preliminary spectral data evaluation. J. Pharm. Sci. 2006, 95 (2), 392– 406.

    OpenUrlPubMed
48. 48.↵
    1. El-Hagrasy A. S.,
    2. Delgado-Lopez M.,
    3. Drennen J. K.

    A process analytical technology approach to near-infrared process control of pharmaceutical powder blending: Part II: Qualitative near-infrared models for prediction of blend homogeneity. J. Pharm. Sci. 2006, 95 (2), 407– 421.

    OpenUrlPubMed
49. 49.↵
    1. El-Hagrasy A. S.,
    2. Drennen J. K.

    A process analytical technology approach to near-infrared process control of pharmaceutical powder blending. Part III: Quantitative near-infrared calibration for prediction of blend homogeneity and characterization of powder mixing kinetics. J. Pharm. Sci. 2006, 95 (2), 422– 434.

    OpenUrlPubMed
50. 50.↵
    1. Shi Z.,
    2. Cogdill R. P.,
    3. Short S. M.,
    4. Anderson C. A.

    Process characterization of powder blending by near-infrared spectroscopy: blend end-points and beyond. J. Pharm. Biomed. Anal. 2008, 47 (4–5), 738– 745.

    OpenUrlPubMed
51. 51.↵
    1. Liew C. V.,
    2. Karande A. D.,
    3. Heng P. W. S.

    In-line quantification of drug and excipients in cohesive powder blends by near infrared spectroscopy. Int. J. Pharm. 2009, 386 (1–2), 138– 148.

    OpenUrlPubMed
52. 52.↵
    1. Sulub Y.,
    2. Wabuyele B.,
    3. Gargiulo P.,
    4. Pazdan J.,
    5. Cheney J.,
    6. Berry J.,
    7. Gupta A.,
    8. Shah R.,
    9. Wu H.,
    10. Khan M.

    Real-time on-line blend uniformity monitoring using near-infrared reflectance spectrometry: a noninvasive off-line calibration approach. J. Pharm. Biomed. Anal. 2009, 49 (1), 48– 54.

    OpenUrlPubMed
53. 53.↵
    1. Vanarase A. U.,
    2. Alcalà M.,
    3. Jerez Rozo J. I.,
    4. Muzzio F. J.,
    5. Romañach R. J.

    Real-time monitoring of drug concentration in a continuous powder mixing process using NIR spectroscopy. Chem. Eng. Sci. 2010, 65 (21), 5728– 5733.

    OpenUrl
54. 54.↵
    1. Koller D. M.,
    2. Posch A.,
    3. Hörl G.,
    4. Voura C.,
    5. Radl S.,
    6. Urbanetz N.,
    7. Fraser S. D.,
    8. Tritthart W.,
    9. Reiter F.,
    10. Schlingmann M.,
    11. Khinast J. G.

    Continuous quantitative monitoring of powder mixing dynamics by near-infrared spectroscopy. Powder Technology 2011, 205 (1–3), 87– 96.

    OpenUrl
55. 55.↵
    1. Gowen A. A.,
    2. O'Donnell C. P.,
    3. Cullen P. J.,
    4. Bell S. E. J.

    Recent applications of chemical imaging to pharmaceutical process monitoring and quality control. Eur. J. Pharm. Biopharm. 2008, 69 (1), 10– 22.

    OpenUrlPubMed
56. 56.↵
    1. Gendrin C.,
    2. Roggo Y.,
    3. Collet C.

    Pharmaceutical applications of vibrational chemical imaging and chemometrics: a review. J. Pharm. Biomed. Anal. 2008, 48 (3), 533– 553.

    OpenUrlPubMed
57. 57.↵
    1. Moes J. J.,
    2. Ruijken M. M.,
    3. Gout E.,
    4. Frijlink H. W.,
    5. Ugwoke M. I.

    Application of process analytical technology in tablet process development using NIR spectroscopy: blend uniformity, content uniformity and coating thickness measurements. Int. J. Pharm. 2008, 357 (1–2), 108– 118.

    OpenUrlPubMed
58. 58.↵
    1. Gupta A.,
    2. Peck G. E.,
    3. Miller R. W.,
    4. Morris K. R.

    Nondestructive measurements of the compact strength and the particle-size distribution after milling of roller compacted powders by near-infrared spectroscopy. J. Pharm. Sci. 2004, 93 (4), 1047– 1053.

    OpenUrlPubMed
59. 59.↵
    1. Yu L. X.,
    2. Lionberger R. A.,
    3. Raw A. S.,
    4. D'Costa R.,
    5. Wu H.,
    6. Hussain A. S.

    Applications of process analytical technology to crystallization processes. Adv. Drug Del. Rev. 2004, 56 (3), 349– 369.

    OpenUrlPubMed
60. 60.↵
    1. Frake P.,
    2. Greenhalgh D.,
    3. Grierson S. M.,
    4. Hempenstall J. M.,
    5. Rudd D. R.

    Process control and end-point determination of a fluid bed granulation by application of near infra-red spectroscopy. Int. J. Pharm. 1997, 151 (1), 75– 80.

    OpenUrl
61. 61.↵
    1. Rantanen J.,
    2. Lehtola S.,
    3. Rämet P.,
    4. Mannermaa J.-P.,
    5. Yliruusi J.

    On-line monitoring of moisture content in an instrumented fluidized bed granulator with a multi-channel NIR moisture sensor. Powder Technology 1998, 99 (2), 163– 170.

    OpenUrl
62. 62.↵
    1. Findlay W. P.,
    2. Peck G. R.,
    3. Morris K. R.

    Determination of fluidized bed granulation end point using near-infrared spectroscopy and phenomenological analysis. J. Pharm. Sci. 2005, 94 (3), 604– 612.

    OpenUrlPubMed
63. 63.↵
    1. Tok A.,
    2. Goh X.,
    3. Ng W.,
    4. Tan R.

    Monitoring granulation rate processes using three PAT tools in a pilot-scale fluidized bed. AAPS PharmSciTech 2008, 9 (4), 1083– 1091.

    OpenUrlPubMed
64. 64.↵
    1. Jørgensen A. C.,
    2. Luukkonen P.,
    3. Rantanen J.,
    4. Schæfer T.,
    5. Juppo A. M.,
    6. Yliruusi J.

    Comparison of torque measurements and near-infrared spectroscopy in characterization of a wet granulation process. J. Pharm. Sci. 2004, 93 (9), 2232– 2243.

    OpenUrlPubMed
65. 65.↵
    1. Räsänen E.,
    2. Rantanen J.,
    3. Mannermaa J.-P.,
    4. Yliruusi J.,
    5. Vuorela H.

    Dehydration studies using a novel multichamber microscale fluid bed dryer with in-line near-infrared measurement. J. Pharm. Sci. 2003, 92 (10), 2074– 2081.

    OpenUrlPubMed
66. 66.↵
    1. Morisseau K. M.,
    2. Rhodes C. T.

    Near-infrared spectroscopy as a nondestructive alternative to conventional tablet hardness testing. Pharm. Res. 1997, 14 (1), 108– 111.

    OpenUrlPubMed
67. 67.↵
    1. Kirsch J. D.,
    2. Drennen J. K.

    Nondestructive tablet hardness testing by near-infrared spectroscopy: a new and robust spectral best-fit algorithm. J. Pharm. Biomed. Anal. 1999, 19 (3–4), 351– 362.

    OpenUrlPubMed
68. 68.↵
    1. Blanco M.,
    2. Alcalá M

    Content uniformity and tablet hardness testing of intact pharmaceutical tablets by near infrared spectroscopy: a contribution to process analytical technologies. Analytica Chimica Acta 2006, 557 (1–2), 353– 359.

    OpenUrl
69. 69.↵
    1. Otsuka M.,
    2. Yamane I.

    Prediction of tablet hardness based on near infrared spectra of raw mixed powders by chemometrics. J. Pharm. Sci. 2006, 95 (7), 1425– 1433.

    OpenUrlPubMed
70. 70.↵
    1. Mattes R.,
    2. Root D.,
    3. Anand O.,
    4. Rajan M. G.,
    5. Trivedi N. R.,
    6. Wen Q.,
    7. Yingxu P.,
    8. Yichun S.

    Near-infrared assay and content uniformity of tablets. Pharm. Technol. 2007, 31 (4), 170– 182.

    OpenUrl
71. 71.↵
    1. Otsuka M.,
    2. Yamane I.

    Prediction of tablet properties based on near infrared spectra of raw mixed powders by chemometrics: scale-up factor of blending and tableting processes. J. Pharm. Sci. 2009, 98 (11), 4296– 4305.

    OpenUrlPubMed
72. 72.↵
    1. Karande A. D.,
    2. Heng P. W. S.,
    3. Liew C. V.

    In-line quantification of micronized drug and excipients in tablets by near infrared (NIR) spectroscopy: real time monitoring of tabletting process. Int. J. Pharm. 2010, 396 (1–2), 63– 74.

    OpenUrlPubMed
73. 73.↵
    1. Buchanan B. R.,
    2. Baxter M. A.,
    3. Chen T. S.,
    4. Qin X.-Z.,
    5. Robinson P. A.

    Use of near-infrared spectroscopy to evaluate an active in a film-coated tablet. Pharm. Res. 1996, 13 (4), 616– 621.

    OpenUrlPubMed
74. 74.↵
    1. Andersson M.,
    2. Folestad S.,
    3. Gottfries J.,
    4. Johansson M. O.,
    5. Josefson M.,
    6. Wahlund K.-G.

    Quantitative analysis of film coating in a fluidized bed process by in-line NIR spectrometry and multivariate batch calibration. Anal. Chem. 2000, 72 (9), 2099– 2108.

    OpenUrlPubMed
75. 75.↵
    1. Pérez-Ramos J.,
    2. Findlay W.,
    3. Peck G.,
    4. Morris K.

    Quantitative analysis of film coating in a pan coater based on in-line sensor measurements. AAPS PharmSciTech 2005, 6 (1), E127– E136.

    OpenUrlPubMed
76. 76.↵
    1. Römer M.,
    2. Heinämäki J.,
    3. Strachan C.,
    4. Sandler N.,
    5. Yliruusi J.

    Prediction of tablet film-coating thickness using a rotating plate coating system and NIR spectroscopy. AAPS PharmSciTech 2008, 9 (4), 1047– 1053.

    OpenUrlPubMed
77. 77.↵
    1. Cahyadi C.,
    2. Karande A. D.,
    3. Chan L. W.,
    4. Heng P. W. S.

    Comparative study of non-destructive methods to quantify thickness of tablet coatings. Int. J. Pharm. 2010, 398 (1–2), 39– 49.

    OpenUrlPubMed
78. 78.↵
    1. Lee M.-J.,
    2. Seo D.-Y.,
    3. Lee H.-E.,
    4. Wang I.-C.,
    5. Kim W.-S.,
    6. Jeong M.-Y.,
    7. Choi G. J.

    In line NIR quantification of film thickness on pharmaceutical pellets during a fluid bed coating process. Int. J. Pharm. 2010, 403 (1–2), 66– 72.

    OpenUrlPubMed
79. 79.↵
    1. Vankeirsbilck T.,
    2. Vercauteren A.,
    3. Baeyens W.,
    4. Van der Weken G.,
    5. Verpoort F.,
    6. Vergote G.,
    7. Remon J. P.

    Applications of Raman spectroscopy in pharmaceutical analysis. TrAC Trends in Analytical Chemistry 2002, 21 (12), 869– 877.

    OpenUrl
80. 80.↵
    1. Bakeev K. A.

    1. Jestel N. L.

    Process Raman Spectroscopy. In Process Analytical Technology: Spectroscopic Tools and Implementation Strategies for the Chemical and Pharmaceutical Industries; Bakeev K. A. Ed.; Blackwell Publishing Ltd.: Oxford, 2005; pp 133– 169.
81. 81.↵
    1. Vergote G. J.,
    2. De Beer T. R. M.,
    3. Vervaet C.,
    4. Remon J. P.,
    5. Baeyens W. R. G.,
    6. Diericx N.,
    7. Verpoort F.

    In-line monitoring of a pharmaceutical blending process using FT-Raman spectroscopy. Eur. J. Pharm. Sci. 2004, 21 (4), 479– 485.

    OpenUrlPubMed
82. 82.↵
    1. Hausman D. S.,
    2. Cambron R. T.,
    3. Sakr A.

    Application of Raman spectroscopy for on-line monitoring of low dose blend uniformity. Int. J. Pharm. 2005, 298 (1), 80– 90.

    OpenUrlPubMed
83. 83.↵
    1. Caillet A.,
    2. Puel F.,
    3. Fevotte G.

    In-line monitoring of partial and overall solid concentration during solvent-mediated phase transition using Raman spectroscopy. Int. J. Pharm. 2006, 307 (2), 201– 208.

    OpenUrlPubMed
84. 84.↵
    1. Wikström H.,
    2. Marsac P. J.,
    3. Taylor L. S.

    In-line monitoring of hydrate formation during wet granulation using Raman spectroscopy. J. Pharm. Sci. 2005, 94 (1), 209– 219.

    OpenUrlPubMed
85. 85.↵
    1. Mantanus J.,
    2. Ziémons E.,
    3. Lebrun P.,
    4. Rozet E.,
    5. Klinkenberg R.,
    6. Streel B.,
    7. Evrard B.,
    8. Hubert P.

    Moisture content determination of pharmaceutical pellets by near infrared spectroscopy: Method development and validation. Analytica Chimica Acta 2009, 642 (1–2), 186– 192.

    OpenUrlPubMed
86. 86.↵
    1. Sandler N.,
    2. Rantanen J.,
    3. Heinämäki J.,
    4. Römer M.,
    5. Marola M.,
    6. Yliruusi J.

    Pellet manufacturing by extrusion-spheronization using process analytical technology. AAPS PharmSciTech 2005, 6 (2), E174– E183.

    OpenUrlPubMed
87. 87.↵
    1. De Beer T. R. M.,
    2. Allesø M.,
    3. Goethals F.,
    4. Coppens A.,
    5. Vander Heyden Y.,
    6. Lopez De Diego H.,
    7. Rantanen J.,
    8. Verpoort F.,
    9. Vervaet C.,
    10. Remon J. P.,
    11. Baeyens W. R.

    Implementation of a process analytical technology system in a freeze-drying process using Raman spectroscopy for in-line process monitoring. Anal. Chem. 2007, 79 (21), 7992– 8003.

    OpenUrlPubMed
88. 88.↵
    1. Johansson J.,
    2. Pettersson S.,
    3. Folestad S.

    Characterization of different laser irradiation methods for quantitative Raman tablet assessment. J. Pharm. Biomed. Anal. 2005, 39 (3–4), 510– 516.

    OpenUrlPubMed
89. 89.↵
    1. Romero-Torres S.,
    2. Pérez-Ramos J. D.,
    3. Morris K. R.,
    4. Grant E. R.

    Raman spectroscopic measurement of tablet-to-tablet coating variability. J. Pharm. Biomed. Anal. 2005, 38 (2), 270– 274.

    OpenUrlPubMed
90. 90.↵
    1. Romero-Torres S.,
    2. Pérez-Ramos J. D.,
    3. Morris K. R.,
    4. Grant E. R.

    Raman spectroscopy for tablet coating thickness quantification and coating characterization in the presence of strong fluorescent interference. J. Pharm. Biomed. Anal. 2006, 41 (3), 811– 819.

    OpenUrlPubMed
91. 91.↵
    1. Kauffman J. F.,
    2. Dellibovi M.,
    3. Cunningham C. R.

    Raman spectroscopy of coated pharmaceutical tablets and physical models for multivariate calibration to tablet coating thickness. J. Pharm. Biomed. Anal. 2007, 43 (1), 39– 48.

    OpenUrlPubMed
92. 92.↵
    1. Pöllänen K.,
    2. Häkkinen A.,
    3. Reinikainen S.-P.,
    4. Rantanen J.,
    5. Karjalainen M.,
    6. Louhi-Kultanen M.,
    7. Nyström L.

    IR spectroscopy together with multivariate data analysis as a process analytical tool for in-line monitoring of crystallization process and solid-state analysis of crystalline product. J. Pharm. Biomed. Anal. 2005, 38 (2), 275– 284.

    OpenUrlPubMed
93. 93.↵
    1. Tewari J.,
    2. Dixit V.,
    3. Malik K.

    On-line monitoring of residual solvent during the pharmaceutical drying process using non-contact infrared sensor: a process analytical technology (PAT) approach. Sensors and Actuators B: Chemical 2010, 144 (1), 104– 111.

    OpenUrl
94. 94.↵
    1. Ho L.,
    2. Müller R.,
    3. Römer M.,
    4. Gordon K. C.,
    5. Heinämäki J.,
    6. Kleinebudde P.,
    7. Pepper M.,
    8. Rades T.,
    9. Shen Y. C.,
    10. Strachan C. J.,
    11. Taday P. F,
    12. Zeitler J. A.

    Analysis of sustained-release tablet film coats using terahertz pulsed imaging. J. Controlled Release 2007, 119 (3), 253– 261.

    OpenUrlPubMed
95. 95.↵
    1. Ho L.,
    2. Müller R.,
    3. Gordon K. C.,
    4. Kleinebudde P.,
    5. Pepper M.,
    6. Rades T.,
    7. Shen Y.,
    8. Taday P. F.,
    9. Zeitler J. A.

    Applications of terahertz pulsed imaging to sustained-release tablet film coating quality assessment and dissolution performance. J. Controlled Release 2008, 127 (1), 79– 87.

    OpenUrlPubMed
96. 96.↵
    1. Ho L.,
    2. Müller R.,
    3. Gordon K. C.,
    4. Kleinebudde P.,
    5. Pepper M.,
    6. Rades T.,
    7. Shen Y.,
    8. Taday P. F.,
    9. Zeitler J. A.

    Terahertz pulsed imaging as an analytical tool for sustained-release tablet film coating. Eur. J. Pharm. Biopharm. 2009, 71 (1), 117– 123.

    OpenUrlPubMed
97. 97.↵
    1. Wu H.,
    2. Heilweil E. J.,
    3. Hussain A. S.,
    4. Khan M. A.

    Process analytical technology (PAT): Effects of instrumental and compositional variables on terahertz spectral data quality to characterize pharmaceutical materials and tablets. Int. J. Pharm. 2007, 343 (1–2), 148– 158.

    OpenUrlPubMed
98. 98.↵
    1. Esbensen K. H.,
    2. Halstensen M.,
    3. Tønnesen Lied T.,
    4. Arild S.,
    5. Svalestuen J.,
    6. de Silva S.,
    7. Hope B.

    Acoustic chemometrics—from noise to information. Chemometrics and Intelligent Laboratory Systems 1998, 44 (1–2), 61– 76.

    OpenUrl
99. 99.↵
    1. Dukhin A. S.,
    2. Goetz P. J.

    Acoustic and electroacoustic spectroscopy for characterizing concentrated dispersions and emulsions. Adv. Colloid Interface Sci. 2001, 92 (1–3), 73– 132.

    OpenUrlPubMed
100. 100.↵
     1. Dukhin A. S.,
     2. Goetz P. J.

     New developments in acoustic and electroacoustic spectroscopy for characterizing concentrated dispersions. Colloids Surf., A 2001, 192 (1–3), 267– 306.

     OpenUrl
101. 101.↵
     1. Halstensen M.,
     2. de Bakker P.,
     3. Esbensen K. H.

     Acoustic chemometric monitoring of an industrial granulation production process—a PAT feasibility study. Chemometrics and Intelligent Laboratory Systems 2006, 84 (1–2), 88– 97.

     OpenUrl
102. 102.↵
     1. Whitaker M.,
     2. Baker G. R.,
     3. Westrup J.,
     4. Goulding P. A.,
     5. Rudd D. R.,
     6. Belchamber R. M.,
     7. Collins M. P.

     Application of acoustic emission to the monitoring and end point determination of a high shear granulation process. Int. J. Pharm. 2000, 205 (1–2), 79– 91.

     OpenUrlPubMed
103. 103.↵
     1. Briens L.,
     2. Daniher D.,
     3. Tallevi A.

     Monitoring high-shear granulation using sound and vibration measurements. Int. J. Pharm. 2007, 331 (1), 54– 60.

     OpenUrlPubMed
104. 104.↵
     1. Papp M.,
     2. Pujara C.,
     3. Pinal R.

     Monitoring of high-shear granulation using acoustic emission: predicting granule properties. Journal of Pharmaceutical Innovation 2008, 3 (2), 113– 122.

     OpenUrl
105. 105.↵
     1. Daniher D.,
     2. Briens L.,
     3. Tallevi A.

     End-point detection in high-shear granulation using sound and vibration signal analysis. Powder Technology 2008, 181 (2), 130– 136.

     OpenUrl
106. 106.↵
     1. Briens L.,
     2. Bojarra M.

     Monitoring fluidized bed drying of pharmaceutical granules. AAPS PharmSciTech 2010, 11 (4), 1612– 1618.

     OpenUrlPubMed
107. 107.↵
     1. Naelapää K.,
     2. Veski P.,
     3. Pedersen J. G.,
     4. Anov D.,
     5. Jørgensen P.,
     6. Kristensen H. G.,
     7. Bertelsen P.

     Acoustic monitoring of a fluidized bed coating process. Int. J. Pharm. 2007, 332 (1–2), 90– 97.

     OpenUrlPubMed
108. 108.↵
     1. Varghese I.,
     2. Cetinkaya C.

     Noncontact photo-acoustic defect detection in drug tablets. J. Pharm. Sci. 2007, 96 (8), 2125– 2133.

     OpenUrlPubMed
109. 109.↵
     1. Akseli I.,
     2. Cetinkaya C.

     Drug tablet thickness estimations using air-coupled acoustics. Int. J. Pharm. 2008, 351 (1–2), 165– 173.

     OpenUrlPubMed
110. 110.↵
     1. Akseli I.,
     2. Cetinkaya C.

     Air-coupled non-contact mechanical property determination of drug tablets. Int. J. Pharm. 2008, 359 (1–2), 25– 34.

     OpenUrlPubMed
111. 111.↵
     1. Akseli I.,
     2. Becker D. C.,
     3. Cetinkaya C.

     Ultrasonic determination of Young's moduli of the coat and core materials of a drug tablet. Int. J. Pharm. 2009, 370 (1–2), 17– 25.

     OpenUrlPubMed
112. 112.↵
     1. Leskinen J. T. T.,
     2. Simonaho S.-P.,
     3. Hakulinen M.,
     4. Ketolainen J.

     In-line ultrasound measurement system for detecting tablet integrity. Int. J. Pharm. 2010, 400 (1–2), 104– 113.

     OpenUrlPubMed
113. 113.↵
     1. Nalluri V. R.,
     2. Schirg P.,
     3. Gao X.,
     4. Virdis A.,
     5. Imanidis G.,
     6. Kuentz M.

     Different modes of dynamic image analysis in monitoring of pharmaceutical dry milling process. Int. J. Pharm. 2010, 391 (1–2), 107– 114.

     OpenUrlPubMed
114. 114.↵
     1. Nalluri V.,
     2. Kuentz M.

     Advancing pharmaceutical dry milling by process analytics and robustness testing. Journal of Pharmaceutical Innovation 2010, 5 (3), 100– 108.

     OpenUrl
115. 115.↵
     1. Mozina M.,
     2. Tomazevic D.,
     3. Leben S.,
     4. Pernus F.,
     5. Likar B.

     Digital imaging as a process analytical technology tool for fluid-bed pellet coating process. Eur. J. Pharm. Sci. 2010, 41 (1), 156– 162.

     OpenUrlPubMed
116. 116.↵
     1. Watano S.

     Direct control of wet granulation processes by image processing system. Powder Technology 2001, 117 (1–2), 163– 172.

     OpenUrl
117. 117.↵
     1. Närvänen T.,
     2. Seppälä K.,
     3. Antikainen O.,
     4. Yliruusi J.

     A new rapid on-line imaging method to determine particle size distribution of granules. AAPS PharmSciTech 2008, 9 (1), 282– 287.

     OpenUrlPubMed
118. 118.↵
     1. Laitinen N.,
     2. Antikainen O.,
     3. Rantanen J.,
     4. Yliruusi J.

     New perspectives for visual characterization of pharmaceutical solids. J. Pharm. Sci. 2004, 93 (1), 165– 176.

     OpenUrlCrossRefPubMedWeb of Science
119. 119.↵
     1. Dieter P.,
     2. Stefan D.,
     3. Günter E.,
     4. Michael K.

     In-line particle sizing for real-time process control by fibre-optical spatial filtering technique (SFT). Advanced Powder Technology 2010, in press.
120. 120.↵
     1. Nir I.,
     2. Johnson B. D.,
     3. Johansson J.,
     4. Schatz C.

     Application of fibre optic dissolution testing for actual products. Pharm. Technol. Eur. 2002, 14 (3), 20.

     OpenUrl
121. 121.↵
     1. Inman G. W.,
     2. Wethington E.,
     3. Baughman K.,
     4. Horton M.

     System optimization for in situ fiber-optic dissolution testing. Pharm. Technol. 2001, 25 (10), 92– 100.

     OpenUrl
122. 122.↵
     1. Ma Z.,
     2. Merkus HG.,
     3. van der Veen H. G.,
     4. Wong M.,
     5. Scarlett B.

     On-line measurement of particle size and shape using laser diffraction. Particle & Particle Systems Characterization 2001, 18 (5–6), 243– 247.

     OpenUrl
123. 123.↵
     1. Chan L.,
     2. Tan L.,
     3. Heng P.

     Process analytical technology: application to particle sizing in spray drying. AAPS PharmSciTech 2008, 9 (1), 259– 266.

     OpenUrlPubMed
124. 124.↵
     1. Matthews L.,
     2. Chandler C.,
     3. Dipali S.,
     4. Adusumilli P.,
     5. Lech S.,
     6. Daskalakis S.,
     7. Mathis N.

     Monitoring blend uniformity with effusivity. Pharm. Technol. 2002, 26 (4), 80.

     OpenUrl
125. 125.↵
     1. Léonard G.,
     2. Bertrand F.,
     3. Chaouki J.,
     4. Gosselin P. M.

     An experimental investigation of effusivity as an indicator of powder blend uniformity. Powder Technology 2008, 181 (2), 149– 159.

     OpenUrl
126. 126.↵
     1. Ghorab M.,
     2. Chatlapalli R.,
     3. Hasan S.,
     4. Nagi A.

     Application of thermal effusivity as a process analytical technology tool for monitoring and control of the roller compaction process. AAPS PharmSciTech 2007, 8 (1), E155– E161.

     OpenUrl
127. 127.↵
     1. Fariss G.,
     2. Keintz R.,
     3. Okoye P.

     Thermal effusivity and power consumption as PAT tools for monitoring granulation end point. Pharm. Technol. 2006, 30 (6), 60– 72.

     OpenUrl
128. 128.↵
     1. Wold S.

     Chemometrics; what do we mean with it, and what do we want from it? Chemometrics and Intelligent Laboratory Systems 1995, 30 (1), 109– 115.

     OpenUrl
129. 129.↵
     1. Workman J. J.

     Review of Chemometrics Applied to Spectroscopy: Quantitative and Qualitative Analysis. The Handbook of Organic Compounds; Academic Press: Burlington, 2001; pp 301– 326.
130. 130.↵
     1. Joe Qin S.

     Statistical process monitoring: basics and beyond. Journal of Chemometrics 2003, 17 (8–9), 480– 502.

     OpenUrlCrossRefWeb of Science
131. 131.↵
     1. Lopes J. A.,
     2. Costa P. F.,
     3. Alves T. P.,
     4. Menezes J. C.

     Chemometrics in bioprocess engineering: process analytical technology (PAT) applications. Chemometrics and Intelligent Laboratory Systems 2004, 74 (2), 269– 275.

     OpenUrl
132. 132.↵
     1. Bakeev K. A.

     1. Miller C. E.

     Chemometrics in Process Analytical Chemistry. In Process Analytical Technology: Spectroscopic Tools and Implementation Strategies for the Chemical and Pharmaceutical Industries; Bakeev K. A. Ed.; Blackwell Publishing Ltd.: Oxford, 2005; pp 226– 328.
133. 133.↵
     1. Brown S. D.

     Chemometrics. John Wiley & Sons, Ltd.: Hoboken, NJ, 2006.
134. 134.↵
     1. Huang J.,
     2. Kaul G.,
     3. Cai C.,
     4. Chatlapalli R.,
     5. Hernandez-Abad P.,
     6. Ghosh K.,
     7. Nagi A.

     Quality by design case study: an integrated multivariate approach to drug product and process development. Int. J. Pharm. 2009, 382 (1–2), 23– 32.

     OpenUrlPubMed
135. 135.↵
     1. Brown S. D.,
     2. Tauler R.,
     3. Walczak B.

     1. Menezes J. C.,
     2. Ferreira A. P.,
     3. Rodrigues L. O.,
     4. Brás L. P.,
     5. Alves T. P.

     Chemometrics Role within the PAT Context: Examples from Primary Pharmaceutical Manufacturing. In Comprehensive Chemometrics; Brown S. D., Tauler R., Walczak B. Eds.; Elsevier: Oxford, 2009; pp 313– 355.
136. 136.↵
     1. Aulton M. E.

     1. Twitchell A. M.

     Mixing. In Aulton's Pharmaceutics: The Design and Manufacture of Medicines, 3rd ed.; Aulton M. E. Ed.; Elsevier Limited: Philadelphia, PA, 2007; pp 152– 167.
137. 137.↵
     1. Aulton M. E.

     1. Summers M. P.,
     2. Aulton M. E.

     Granulation. In Aulton's Pharmaceutics: The Design and Manufacture of Medicines 3rd ed. Aulton M. E. Ed.; Elsevier Limited: Philadelphia, PA, 2007; pp 410– 424.
138. 138.↵
     1. Davis T. D.,
     2. Morris K. R.,
     3. Huang H.,
     4. Peck G. E.,
     5. Stowell J. G.,
     6. Eisenhauer B. J.,
     7. Hilden J. L.,
     8. Gibson D.,
     9. Byrn S. R.

     In situ monitoring of wet granulation using online X-Ray powder diffraction. Pharm. Res. 2003, 20 (11), 1851– 1857.

     OpenUrlPubMed
139. 139.↵
     1. Talu I.,
     2. Tardos G. I.,
     3. Ruud van Ommen J.

     Use of stress fluctuations to monitor wet granulation of powders. Powder Technology 2001, 117 (1–2), 149– 162.

     OpenUrl
140. 140.↵
     1. Aulton M. E.

     1. Staniforth J. N.,
     2. Aulton M. E.

     Paricle Size Reduction. In Aulton's Pharmaceutics: The Design and Manufacture of Medicines, 3rd ed.; Aulton M. E. Ed.; Elsevier Limited: Philadelphia, PA, 2007; pp 137– 144.
141. 141.↵
     1. Aulton M. E.

     1. Staniforth J. N.,
     2. Aulton M. E.

     Particle Size Analysis. In Aulton's Pharmaceutics: The Design and Manufacture of Medicines, 3rd ed.; Aulton M. E. Ed.; Elsevier Limited: Philadelphia, PA, 2007; pp 121– 136.
142. 142.↵
     1. Aulton M. E.

     1. Aulton M. E.

     Drying. In Aulton's Pharmaceutics: The Design and Manufacture of Medicines, 3rd ed.; Aulton M. E. Ed.; Elsevier Limited: Philadelphia, PA, 2007; pp 425– 440.
143. 143.↵
     1. Aulton M. E.

     1. Alderborn G.

     Tablets and Compaction. In Aulton's Pharmaceutics: The Design and Manufacture of Medicines, 3rd ed.; Aulton M. E. Ed.; Elsevier Limited: Philadelphia, PA, 2007; pp 441– 482.
144. 144.↵
     1. Virtanen S.,
     2. Antikainen O.,
     3. Yliruusi J.

     Determination of the crushing strength of intact tablets using Raman spectroscopy. Int. J. Pharm. 2008, 360 (1–2), 40– 46.

     OpenUrlPubMed
145. 145.↵
     1. Aulton M. E.

     1. Porter S. C.

     Coating of tablets and multiparticles. In Aulton's Pharmaceutics: The Design and Manufacture of Medicines, 3rd ed.; Aulton M. E. Ed.; Elsevier Limited: Philadelphia, PA, 2007; pp 500– 514.
146. 146.↵
     FDA. 2003 Comparability Protocols: Chemistry, Manufacturing, and Controls Information. http://www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/ucm052510.pdf.
147. 147.↵
     1. McCormick D.

     PAT survey reflects optimism, uncertainty. Pharm. Technol. 2005, 29 (1), 24.

     OpenUrl
148. 148.↵
     1. Drakulich A.

     Critical challenges to implementing QbD: A Q&A with FDA. Pharm. Technol. 2009, 33 (10), 90– 94.

     OpenUrl
149. 149.↵
     1. Valporsson H.

     PAT implementation in pharmaceutical manufacturing and its economical impact. PhD Thesis 2006, University of Basel, Switzerland. http://edoc.unibas.ch/diss/DissB_8178.
150. 150.↵
     1. Cogdill R.,
     2. Knight T.,
     3. Anderson C.,
     4. Drennen J.

     The financial returns on investments in process analytical technology and lean manufacturing: benchmarks and case study. Journal of Pharmaceutical Innovation 2007, 2 (1), 38– 50.

     OpenUrl
151. 151.↵
     1. EMA.

     2011 22 March 2012. “EMA-FDA Pilot Program for Parallel Assessment of Quality by Design Applications” (EMA/172347/2011) http://www.ema.europa.eu/docs/en_GB/document_library/other/2011/03/wc500103621.pdf.